Nuvectis Pharma Inc. (NVCT)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
19. 14
+0.54
+2.9032%
$
485.35M Market Cap
- P/E Ratio
- Div Yield
331,000 Volume
-1.52 Eps
$ 18.6
Previous Close 
Want to track NVCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NVCT Earnings Reports FAQ
What is the earnings per share (EPS) for NVCT?
The current EPS is -1.52.
What is the company's earnings growth rate?
Nuvectis Pharma Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Nuvectis Pharma Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nuvectis Pharma Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NVCT at this time, as Nuvectis Pharma Inc has no recent EPS data to calculate it.
